Novartis passes on $550M option to buy Proteon Therapeutics By: Kansas City Business Journal via Business Journals March 18, 2014 at 13:19 PM EDT Swiss pharmaceutical company Novartis AG has declined to exercise a $550 million option agreement to purchase Proteon Therapeutics Inc... Read More >> Related Stocks: Novartis Ag ADR